Our story began in 1997 at our headquarters in Oslo, Norway. Photocure began with a focus on developing and improving photodynamic technology. Over the years our focus changed, still grounded in the world of photodynamic technology, we evolved our vision to become a bladder cancer speciality company.
In collaboration with our partners, we are dedicated to improving outcomes for patients all around the world. It’s a dedication that can be seen in our products and services, providing transformative solutions that improve the management of bladder cancer, as well as helping us become a global leader in the field.
Based on the Photocure Technology® platform, Photocure has developed and commercialized Hexvix® and Cysview® for use in bladder cancer.
Cysview® is the trademark in the U.S. and Canada, and Hexvix® is the trademark in all other countries.
|